活血通降法联合穴位贴敷治疗瘀血阻络型反流性食管炎临床观察

The clinical observation on Huoxue Tongjiang method combined with acupoint application in the treatment of blood stasis reflux esophagitis

[目的]观察活血通降法联合穴位贴敷治疗瘀血阻络型反流性食管炎临床观察。[方法]将86例中医辨证为瘀血阻络型反流性食管炎患者随机分为对照组和治疗组各43例。对照组采用西药雷贝拉唑20 mg/次,早饭前半小时口服,1次/d,疗程为8周。治疗组在对照组的基础上加用中药活血通降法联合穴位贴敷。治疗后对各项指标进行观察比较。[结果]治疗组与对照组临床总有效率比较差异有统计学意义(P<0.05)。2组反流性食管炎患者主症治疗前后症状积分比较差异有统计学意义(P<0.05)。2组反流性食管炎患者次症治疗前后症状积分比较(P<0.05)。2组患者治疗前后内镜积分的比较(P<0.05)。2组患者治疗前后胃排空T1/2和Tlag比较差异有统计学意义(P<0.05)。2组患者治疗前后胃动素、胃泌素比较差异有统计学意义(P<0.05)。[结论]在常规西药治疗基础上加用活血通降法联合穴位贴敷治疗瘀血阻络型反流性食管炎提高临床疗效,防止复发,使患者获得更好的远期疗效。

[Objective]Clinical observation on Huoxue Tongjiang method combined with acupoint application in the treatment of blood stasis reflux esophagitis.[Methods]86 patients with reflux blood stasis esophagitis were randomly divided into control group and treatment group.The control group used the Western drug raprazole 20 mg/time,oral half an hour before breakfast,1/day,and the course was 8 weeks.On the basis of the control group,the treatment group was applied with the Chinese medicine Huoxue method and the acupoint application.Observation of various indicators after treatment.[Results]Comparison of total clinical efficiency between treatment group and control group was statistically significant(P<0.05).The difference in symptom scores between two groups of patients with reflux esophagitis was statistically significant(P<0.05).The difference of secondary symptoms after treatment between two groups of reflux esophagitis patients was statistically significant(P<0.05).Comparison of endoscopic score after treatment between two groups of patients was statistically significant(P<0.05).The difference between T1/2 and Tag after treatment was statistically significant(P<0.05).The difference of motilin and gastrin between two groups was statistically significant(P<0.05).[Conclusion]On the basis of the conventional Western medicine,the Huoxue Tongjiang method combined with acupoint application in the treatment of blood stasis reflux esophagitis can improve clinical efficacy.